Cha University
Clinical trials sponsored by Cha University, explained in plain language.
-
New combo therapy aims to outsmart liver Cancer's hiding spots
Disease control CompletedThis study looked at whether a combination of two drugs (atezolizumab and bevacizumab) could better control advanced liver cancer, especially tumors located in the liver itself. Researchers tested this in 131 patients with advanced liver cancer who had not yet received other drug…
Sponsor: CHA University • Aim: Disease control
Last updated Apr 02, 2026 00:42 UTC
-
Scientists search for clues in liver cancer Patients' blood and tissue
Knowledge-focused CompletedThis study aimed to discover biological markers that could predict how patients with advanced liver cancer respond to a specific drug combination. Researchers analyzed blood and tumor tissue samples from 166 patients who had already received the treatment. The goal was to find pa…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC